Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.
about
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?Lipidomics-Reshaping the Analysis and Perception of Type 2 DiabetesGlial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expressionCoordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primatesTopiramate-induced modulation of hepatic molecular mechanisms: an aspect for its anti-insulin resistant effectSmall molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humansLinagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesityMitochondrial Trifunctional Protein Defects: Clinical Implications and Therapeutic ApproachesFatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signalingValue of MRI and MRS fat measurements to complement conventional screening methods for childhood obesity.Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.Fetuin-A induces cytokine expression and suppresses adiponectin production.Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegalyObesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Molecular mechanisms involved in hepatic steatosis and insulin resistance.Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans.Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis.In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation.Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study.Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity.Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine modelGender differences in insulin resistance, body composition, and energy balance.Associations between longer habitual day napping and non-alcoholic fatty liver disease in an elderly Chinese population.The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat.The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetesRelationships of circulating sex hormone-binding globulin with metabolic traits in humans.ADV36 adipogenic adenovirus in human liver disease.Acetylcholinesterase (AChE) inhibition aggravates fasting-induced triglyceride accumulation in the mouse liverLiver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.Palmitic acid induces osteoblastic differentiation in vascular smooth muscle cells through ACSL3 and NF-κB, novel targets of eicosapentaenoic acidHepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver diseaseDirect inhibitory effects of pioglitazone on hepatic fetuin-A expressionLack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.The metabolically benign and malignant fatty liver.Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies.Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance.Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.
P2860
Q27006992-6B22CF72-33B5-4527-AB6D-7D241C489AEBQ28073169-B74B1498-C3F5-44BC-9657-26B99411BE86Q28354027-02A7C67C-6697-479F-97ED-D6D6ADD02049Q28478084-8A73CB1A-85B2-4EAD-AC16-9974CB113D1AQ28483904-01C2C861-D8B2-4F61-9735-506DC6ACB91BQ28576077-46A4C69F-79FC-4997-9438-E08596F5984FQ28728101-1E02C9BE-2772-4CC3-AF08-011EB3710F8DQ28972544-2F8862E2-3EB3-4712-88A2-63AB989F3996Q29616024-FF1F6891-853C-435A-9D1B-39E9F8CBCB4DQ30934313-5372E6AB-F8E0-4D26-9ADC-D5BD3CFEB52DQ33283340-9D6DCE4D-1DEA-4665-896A-6F342745D0D0Q33323370-99E1F626-99A8-437E-8763-038E4783A640Q33394238-876A6357-26F1-4DB6-B1A7-59CC3D8C7076Q33580624-4ACF750F-B1EE-4A64-B416-C07AF94CD476Q33585604-81BAED63-1318-4AA5-8E24-DB4FA9E3F9FAQ33602334-01DE2BDA-27EC-49CF-9685-D3CB48247586Q33735381-D4A99B1B-B8D6-4F0D-97F5-234A094CEA84Q33817177-0AD1CCFF-29A5-4B39-94F2-168AF214E611Q33867427-35442F86-E8CC-4A6B-AFD8-9E7D7996D7FDQ33932928-24A27F6A-B136-44C6-9504-8DF80A09D503Q33940924-6031F3B4-0FB0-4DDB-821C-84F49C5A6D24Q33998998-7090F772-28AC-4F1D-BAA7-39B68C47D090Q34013754-253A1428-5DAC-4007-8CAE-F6A5623CAB3BQ34070970-D8557BE8-DAFF-4B5E-BBDC-4F67EB90F8FBQ34091146-430F800F-27A9-44D5-96EE-91487C8D6998Q34113485-E020D3EE-121B-4AE8-8086-C72D5007D8B0Q34185998-D35C7972-4918-4F53-8845-E60C5941D6F1Q34355301-4B02921E-0795-4301-A1E0-44FC1B366558Q34405050-11CF9670-16D8-4810-A621-9AAD1621B905Q34466808-8104DCC4-CCDF-4E2C-ACA9-1D6F1FA9DDE5Q34507251-59D88115-C634-406C-B19C-33328A7FCB3CQ34808602-4EE64A4B-9E1C-4D7D-95BF-BFE666182DA8Q34988788-8AB68CAD-4E59-4E69-8A1C-7243E7B5ED8BQ35097489-B9DC9A76-BEBF-460D-8F7E-DD02C8B5C939Q35102868-AEDBEE84-FB74-4053-A28D-C3D93E33981CQ35123495-2D089099-A453-459E-AE99-D433D9734341Q35124342-4CA9C62C-D094-46D6-AB4D-D0DFA5974B81Q35147540-2F5E8B16-1074-47A2-BF51-371442D82056Q35882617-0A87FBBA-BB30-409B-AEC2-E415428244D1Q35972690-55356FF7-10A6-4698-8ED5-6E3EB2838387
P2860
Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mechanisms of Disease: hepatic ...... enesis and clinical relevance.
@ast
Mechanisms of Disease: hepatic ...... enesis and clinical relevance.
@en
type
label
Mechanisms of Disease: hepatic ...... enesis and clinical relevance.
@ast
Mechanisms of Disease: hepatic ...... enesis and clinical relevance.
@en
prefLabel
Mechanisms of Disease: hepatic ...... enesis and clinical relevance.
@ast
Mechanisms of Disease: hepatic ...... enesis and clinical relevance.
@en
P356
P1476
Mechanisms of Disease: hepatic ...... enesis and clinical relevance.
@en
P2093
Michael Roden
P2860
P304
P356
10.1038/NCPENDMET0190
P577
2006-06-01T00:00:00Z